uniQure (QURE) EBITDA Margin (2016 - 2026)
uniQure (QURE) recorded EBITDA Margin of -809.72% in Q2 2026, down 45.09 percentage points from -764.63% a year earlier but up 390.84 percentage points from the prior quarter.
Powered by 
Analysis
uniQure (QURE) EBITDA Margin (2016 - 2026) Analysis & Trends
On a TTM basis, uniQure's EBITDA Margin came in at -994.06% as of Jun 30, 2026, up 78.36 percentage points year-over-year; for FY2025, it came in at -1059.70%, down 426.73 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of -753.74 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -632.96% in FY2024 (+1077.39 pp), -1710.35% in FY2023 (-1583.93 pp), -126.43% in FY2022 (-187.10 pp) and 60.67% in FY2021 (+366.63 pp).
- Quarterly EBITDA Margin has ranged from -10881.29% in Q2 2022 to 28.06% in Q4 2022 over the past five years.
- On a year-over-year basis, EBITDA Margin rose in four of the last eight quarters, with an average year-over-year change of +414.88 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 8301.35 percentage points in Q2 2023, against a drop of 10967.48 percentage points in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -1200.56% (Q1 2026), -864.73% (Q4 2025) and -1280.82% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,135.59 Bn | 1,104.17 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 616.92 Bn | 535.45 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 501.52 Bn | 474.63 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 367.36 Bn | 321.74 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 297.93 Bn | 261.92 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.45 Bn | 235.14 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 236.40 Bn | 191.80 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 190.72 Bn | 164.92 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 169.43 Bn | 116.08 Bn | 10.94 Bn | 39.16% |
| 10 | uniQure | 1.49 Bn | -1.22 Bn | 5.49 Mn | -870.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -870.88% |
| Mar 31, 2026 | -1,322.26% |
| Dec 31, 2025 | -943.25% |
| Sep 30, 2025 | -1,332.91% |
| Jun 30, 2025 | -803.52% |
| Mar 31, 2025 | -2,356.16% |
| Dec 31, 2024 | -840.85% |
| Sep 30, 2024 | -1,707.13% |
| Jun 30, 2024 | -398.32% |
| Mar 31, 2024 | -651.67% |
| Dec 31, 2023 | -926.12% |
| Sep 30, 2023 | -5,968.16% |
| Jun 30, 2023 | -2,617.59% |
| Mar 31, 2023 | -1,362.82% |
| Dec 31, 2022 | 28.06% |
| Sep 30, 2022 | -3,962.39% |
| Jun 30, 2022 | -10,881.29% |
| Mar 31, 2022 | -2,899.44% |
| Dec 31, 2021 | 6.79% |
| Sep 30, 2021 | -2,172.95% |
API Access
uniQure EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=QURE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "QURE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=QURE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();